These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4242418)

  • 41. [The effect of coronary dilator drugs on oxygen pressure and blood supply of the dog myocardium, normal and with coronary insufficiency].
    Kadatz R
    Arch Kreislaufforsch; 1969; 58(3):263-93. PubMed ID: 4979382
    [No Abstract]   [Full Text] [Related]  

  • 42. ["Extracoronary" effect of carbochromen on the circulation].
    Votcal BE; Zmurkin VP; Rogunov GA; Trosina TP; Alijeva ZM
    Arzneimittelforschung; 1970 Mar; 20():442-6. PubMed ID: 5468727
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of 2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-D)pyrimidine (RA233) on the coronary circulation of the acutely transplanted dog heart: comparison with dipyridamole and adenosine.
    Paoloni HJ; Wilcken DE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):137-45. PubMed ID: 4562619
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes of the coronary arteriovenous O2 difference in the man following intravenous injection of dipyridamol (Persantin)].
    Hilger HH; Wagner J; Hellwig H; Louven B; Wackerbauer J; Schaede A
    Z Kreislaufforsch; 1967 Dec; 56(12):1192-206. PubMed ID: 5593119
    [No Abstract]   [Full Text] [Related]  

  • 45. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 46. Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
    Sano N; Sato S; Hashimoto K
    Jpn J Pharmacol; 1972 Dec; 22(6):857-65. PubMed ID: 4541491
    [No Abstract]   [Full Text] [Related]  

  • 47. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacological activity of some 8-diethylaminomethyl N-methylated xanthines and hypoxanthines].
    Liberman SS; Al'tshuler RA; Gerchikov LN
    Farmakol Toksikol; 1970; 33(5):586-90. PubMed ID: 5493219
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
    Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
    Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
    [No Abstract]   [Full Text] [Related]  

  • 50. [On pharmacoogical effects on the nervous regulation of the coronary circulation].
    Kaverina NV
    Vestn Akad Med Nauk SSSR; 1966; 21(4):9-15. PubMed ID: 6002421
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow].
    Hensel I; Bretschneider HJ; Kettler D; Knoll D; Kochsiek K; Reploh HD; Spieckermann PG; Tauchert M
    Arzneimittelforschung; 1972 Apr; 22(4):652-63. PubMed ID: 5068243
    [No Abstract]   [Full Text] [Related]  

  • 52. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacodynamic study of a new vasodilator, cinepazide maleate I -Vasodilating action].
    Pourrias B; Bouvet P; Raynaud G
    Therapie; 1974; 29(1):29-41. PubMed ID: 4849379
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacological effects on coronary reactive hyperemia in conscious dogs.
    Juhran W; Voss EM; Dietmann K; Schaumann W
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):32-47. PubMed ID: 4252441
    [No Abstract]   [Full Text] [Related]  

  • 55. [Action of trinitrin on coronary flow].
    Warembourg H; Houdas Y; Bertrand M; Ketelers JY
    Lille Med; 1969; 14(4):377-82. PubMed ID: 4978294
    [No Abstract]   [Full Text] [Related]  

  • 56. [The effect of pharmacologic agents coronary circulation in experimental spasms of heart vessels].
    Kareva GF
    Vestn Akad Med Nauk SSSR; 1963; 18(1):28-32. PubMed ID: 4971961
    [No Abstract]   [Full Text] [Related]  

  • 57. Enhancement of coronary vasodilating action of adenosine by dilazep and dipyridamole in the dog.
    Sano N
    Jpn J Pharmacol; 1974 Jun; 24(3):471-8. PubMed ID: 4449152
    [No Abstract]   [Full Text] [Related]  

  • 58. Potentiation of the coronary vasodilator effect of norepinephrine by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole).
    Hashimoto K; Sano N
    Tohoku J Exp Med; 1968 Oct; 96(2):207-8. PubMed ID: 5708523
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indications for coronary dilators].
    Hashimoto K
    Nihon Ishikai Zasshi; 1971 Nov; 66(9):918-25. PubMed ID: 5169317
    [No Abstract]   [Full Text] [Related]  

  • 60. Transmural gradient of NAD-NADPH ratio in their canine left ventricular myocardium, and effects of coronary dilators on the transmural gradient.
    Minamidate A; Takano S; Hashikawa T; Abiko Y
    Jpn J Pharmacol; 1973 Feb; 23(1):126-8. PubMed ID: 4352412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.